PuraPharm Corp. Ltd. Financial Overview
PuraPharm Corp. Ltd.'s market cap is currently HK$195.25M. The company's EPS TTM is HK$-0.055; its P/E ratio is -3.74; PuraPharm Corp. Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
